Compass Therapeutics, Inc.’s CMPX share price has surged by 14.18%, which has investors questioning if this is right time to ...

A research team revealed that insulin-like growth factor-binding protein 6 (IGFBP6) serves as a potential therapeutic target ...

Glaucoma is a complex and multifactorial neurodegenerative disorder primarily characterized by the progressive loss of retinal ganglion cells (RGCs) and their axons, leading to irreversible visual ...

ONS-5010 (bevacizumab-vikg) was found to be noninferior to ranibizumab for neovascular age-related macular degeneration at week 12.

VMPL New Delhi [India]7 As hair thinning and skin aging continue to be prevalent concerns worldwide VCare latest GFC ...

【导读】血管完整性受损促进癌细胞外渗和转移。然而，结直肠癌（CRC）中导致血管完整性破坏的机制仍不清楚。1月21日，济宁医学院研究团队在期刊《Cell Death&Disease》上发表了研究论文，题为“PCDH17 induces ...

At a single academic tertiary referral center, mild intraocular inflammation developed in four eyes following intravitreal ...

A research team led by Prof. WENG Jianping from the University of Science and Technology of China (USTC) of the Chinese ...

January 23, 2025) - Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) securities between November 2, 2023 and October 30, 2024, ...

ISELIN, N.J. - Outlook Therapeutics, Inc. (NASDAQ:OTLK), a clinical-stage biopharmaceutical company with a current market capitalization of $52 million, reported at the Hawaiian Eye and Retina 2025 ...

When compared with reference aflibercept, a biosimilar ranibizumab was a clinically effective and cost-saving alternative in ...